The activated form of VLA4 binds with high affinity to the ligands, fibronectin and VCAM-1 expressed on BM stromal cells, increasing myeloma cell adhesion and survival within the BM microenvironment11,12. The gene discussed is VCAM1; the disease is plasma cell myeloma.